Pamela Clax

Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials

Victor G De Gruttola, Pamela Clax, David L. DeMets et al. · Controlled Clinical Trials · 2001 · 423 citations

Pharmacy, Biostatistics, Good Clinical Practice +11

Depo-medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions

Susan E. Cohn, J-G Park, D. Heather Watts et al. · Clinical Pharmacology & Therapeutics · 2006 · 79 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093

D. Heather Watts, Jeong-Gun Park, Susan E. Cohn et al. · Contraception · 2007 · 60 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +7

Pharmacokinetics of Didanosine in Antepartum and Postpartum Human Immunodeficiency Virus–Infected Pregnant Women and Their Neonates:An AIDS Clinical Trials Group Study

Yi Wang, Elizabeth Livingston, Shivakumar Patil et al. · The Journal of Infectious Diseases · 1999 · 51 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

A Phase-I Study of the Safety, Pharmacokinetics, and Antiviral Activity of Combination Didanosine and Ribavirin in Patients with HIV-1 Disease

Anthony J. Japour, Juan J.L. Lertora, Patricia M. Meehan et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1996 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +17